537 related articles for article (PubMed ID: 24829369)
1. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.
Ise T; Hasegawa T; Morita Y; Yamada N; Funada A; Takahama H; Amaki M; Kanzaki H; Okamura H; Kamakura S; Shimizu W; Anzai T; Kitakaze M
Heart; 2014 Aug; 100(15):1165-72. PubMed ID: 24829369
[TBL] [Abstract][Full Text] [Related]
2. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.
Greulich S; Deluigi CC; Gloekler S; Wahl A; Zürn C; Kramer U; Nothnagel D; Bültel H; Schumm J; Grün S; Ong P; Wagner A; Schneider S; Nassenstein K; Gawaz M; Sechtem U; Bruder O; Mahrholdt H
JACC Cardiovasc Imaging; 2013 Apr; 6(4):501-11. PubMed ID: 23498675
[TBL] [Abstract][Full Text] [Related]
3. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.
Watanabe E; Kimura F; Nakajima T; Hiroe M; Kasai Y; Nagata M; Kawana M; Hagiwara N
J Thorac Imaging; 2013 Jan; 28(1):60-6. PubMed ID: 23249970
[TBL] [Abstract][Full Text] [Related]
4. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
[TBL] [Abstract][Full Text] [Related]
5. Right ventricular involvement is an important prognostic factor and risk stratification tool in suspected cardiac sarcoidosis: analysis by cardiac magnetic resonance imaging.
Kagioka Y; Yasuda M; Okune M; Kakehi K; Kawamura T; Kobuke K; Miyazaki S; Iwanaga Y
Clin Res Cardiol; 2020 Aug; 109(8):988-998. PubMed ID: 31872264
[TBL] [Abstract][Full Text] [Related]
6. Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.
Yang Y; Safka K; Graham JJ; Roifman I; Zia MI; Wright GA; Balter M; Dick AJ; Connelly KA
J Magn Reson Imaging; 2014 Mar; 39(3):609-16. PubMed ID: 23720077
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and prognostic significance of left ventricular myocardial late gadolinium enhancement in severe aortic stenosis.
Rajesh GN; Thottian JJ; Subramaniam G; Desabandhu V; Sajeev CG; Krishnan MN
Indian Heart J; 2017; 69(6):742-750. PubMed ID: 29174252
[TBL] [Abstract][Full Text] [Related]
8. New insights into peripartum cardiomyopathy using cardiac magnetic resonance imaging.
Renz DM; Röttgen R; Habedank D; Wagner M; Böttcher J; Pfeil A; Dietz R; Kivelitz D; Elgeti T
Rofo; 2011 Sep; 183(9):834-41. PubMed ID: 21830182
[TBL] [Abstract][Full Text] [Related]
9. Right ventricular involvement and the extent of left ventricular enhancement with magnetic resonance predict adverse outcome in pulmonary sarcoidosis.
Smedema JP; van Geuns RJ; Ector J; Heidbuchel H; Ainslie G; Crijns HJGM
ESC Heart Fail; 2018 Feb; 5(1):157-171. PubMed ID: 28967698
[TBL] [Abstract][Full Text] [Related]
10. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.
Nagai T; Kohsaka S; Okuda S; Anzai T; Asano K; Fukuda K
Chest; 2014 Oct; 146(4):1064-1072. PubMed ID: 24853830
[TBL] [Abstract][Full Text] [Related]
11. Late gadolinium enhancement in cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy complicated by life-threatening ventricular tachyarrhythmia.
Petkow-Dimitrow P; Klimeczek P; Vliegenthart R; Pasowicz M; Miszalski-Jamka T; Oudkerk M; Podolec P; Dubiel JS; Tracz W
Kardiol Pol; 2009 Aug; 67(8A):964-9. PubMed ID: 19784900
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Prognostic Value of Late Gadolinium-Enhanced Magnetic Resonance Imaging in Patients With and Without Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Grafting.
Lee SA; Yoon YE; Kim JE; Park JJ; Oh IY; Yoon CH; Suh JW; Kim JS; Chun EJ; Cho YS; Youn TJ; Lim C; Cho GY; Chae IH; Park KH; Choi DJ; Choi SI
Am J Cardiol; 2016 Dec; 118(11):1647-1654. PubMed ID: 27742424
[TBL] [Abstract][Full Text] [Related]
13. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
[TBL] [Abstract][Full Text] [Related]
14. The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study.
Kim EK; Lee GY; Jang SY; Chang SA; Kim SM; Park SJ; Choi JO; Park SW; Choe YH; Lee SC; Oh JK
Korean J Radiol; 2021 Mar; 22(3):324-333. PubMed ID: 32932562
[TBL] [Abstract][Full Text] [Related]
15. Late gadolinium enhancement in cardiac transplant patients is associated with adverse ventricular functional parameters and clinical outcomes.
Butler CR; Kumar A; Toma M; Thompson R; Chow K; Isaac D; Kim D; Haykowsky M; Friedrich MG; Paterson I
Can J Cardiol; 2013 Sep; 29(9):1076-83. PubMed ID: 23380296
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy.
Smith BM; Dorfman AL; Yu S; Russell MW; Agarwal PP; Mahani MG; Lu JC
Am J Cardiol; 2014 Apr; 113(7):1234-9. PubMed ID: 24513464
[TBL] [Abstract][Full Text] [Related]
18. Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.
Lin LY; Su MY; Chen JJ; Lai LP; Hwang JJ; Tseng CD; Chen YS; Yu HY; Tseng WY; Lin JL
JACC Cardiovasc Imaging; 2013 Nov; 6(11):1152-9. PubMed ID: 24229767
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
[TBL] [Abstract][Full Text] [Related]
20. Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
Ammirati E; Moroni F; Sormani P; Peritore A; Milazzo A; Quattrocchi G; Cipriani M; Oliva F; Giannattasio C; Frigerio M; Roghi A; Camici PG; Pedrotti P
Int J Cardiol; 2017 Mar; 231():216-221. PubMed ID: 27913009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
